Menu Close

Factal and Emergent Risk International’s webinar series examines COVID-19’s chaotic recovery

Typewriter keys spell out COVID 19 - with a spacebar between the "1" and the "9".

Every other Thursday, Factal and Emergent Risk International are co-hosting a webinar series on the COVID-19 recovery. We’re not alone in this – inboxes around the world are filled with coronavirus webinars, often pitching a product or service.

What makes this series different is two experienced teams take an objective look at the likely path of the the recovery and what it means for global organizations. Attendees hear the very latest on news developments from around the globe (that’s from us at Factal) and what’s likely to happen in the future (from the analysts at Emergent Risk International).

Tomorrow’s webinar will be the seventh in this ongoing series. If you can’t make it, register anyway – and we’ll send you the recording and slides.

Here’s a sample of what our VP of Product/News, Cory Bergman, shared at the last webinar:

“A lockdown isn’t a cure. It’s just a restart. It’s something that I think the public doesn’t fully understand. We always see that flattening the curve. And we think that once we get at the back end of that curve, it’s all good. But if you remove the lockdown, and there isn’t social distancing, if it’s effectively put into place, and there isn’t contact tracing and testing, and isolation, then you get to R-over-one again.

So how are the states doing with testing and tracing? And the answer is, it’s all over the place, right? You have the top five states in test per million people on a cumulative basis on the left, the low, the bottom five on the right. So you have a combination of low population states and states that have been very aggressive in testing due to early onset. So Rhode Island, New York, North Dakota, Massachusetts and Louisiana.

And then the other side, I mean, the numbers are just so different, that there’s really — it’s like we’re in the United States of 50 countries. I mean, everybody has a different set of circumstances, different set of testing capabilities, different politics, different behaviors. And so this is what gets really challenging. Obviously, if you’re a company operating in the United States, where you have to have different approaches to each one of those locations.”

Tune in tomorrow – and every other Thursday – for news and analysis about COVID-19 that you won’t see anywhere else. The journalists and analysts are also available for questions.

Top photo by Junwei Ren on Unsplash.